GastroHep

Keyphrases

Publications

volume 3, number 2, 2021

Ricky Sinharay, Andrew J Grant, Lucy Rivett, Rebecca Blackwell, George Mells, William Gelson
Assessing efficacy of hepatocellular carcinoma prediction scores to prioritise hepatitis B surveillance in the COVID-19 era. GastroHep 3 (2) (2021)

volume 3, number 3, 2021

Anna Licata, Maria Giovanna Minissale, Marco Distefano, Giuseppe Montalto
Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know? GastroHep 3 (3) (2021)
Donna M Evon, Hsing-Hua S Lin, Robert J Fontana, Mandana Khalili, Colina Yim, Abdus S Wahed, Jay H Hoofnagle
Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B. GastroHep 3 (3) (2021)

volume 3, number 4, 2021

Ralley E Prentice, Clarissa Rentsch, Aysha H Al-Ani, Eva Zhang, Douglas Johnson, John Halliday, Robert V Bryant, Jacob Begun, Mark G Ward, Peter J Lewindon, Susan J Connor, Simon Ghaly, Britt Christensen
SARS-CoV-2 vaccination in patients with inflammatory bowel disease. GastroHep 3 (4) (2021)

2020

Hidenori Toyoda, Satoshi Yasuda, Seiki Kiriyama, Makoto Tanikawa, Yasuhiro Hisanaga, Akira Kanamori, Shusuke Kitabatake, Satoshi Yamamoto, Shohei Shiota, Manabu Furoi, Takahiro Koyabu, Daiju Furukawa, Takashi Kumada, Yoshio Sumida
Impact of COVID-19 pandemic on surveillance of hepatocellular carcinoma: a study in patients with chronic hepatitis C after sustained virologic response. GastroHep (2020)

volume 2, number 2, 2020

Jasmohan Singh Bajaj, Chathur Acharya, Masoumeh Sikaroodi, Patrick M Gillevet, Leroy R Thacker
Cost-effectiveness of integrating gut microbiota analysis into hospitalisation prediction in cirrhosis. GastroHep 2 (2) (2020)

volume 2, number 3, 2020

Her Hsin Tsai
COVID -19 and the gastroenterologist. GastroHep 2 (3) (2020)

volume 2, number 4, 2020

Shria Kumar, David C Metz, David E Kaplan, David S Goldberg
The association of Helicobacter pylori with pancreatic cancer. GastroHep 2 (4) (2020)

volume 2, number 6, 2020

Esha Sharma, Susanna Meade, Francesca D'Errico, Polychronis Pavlidis, Raphael Luber, Sebastian Zeki, Katie Hill, Alexa Duff, Dearbhaile O'Hanlon, Sherill Tripoli, Anna Stanton, Andra Caracostea, Sailish Honap, Rebecca Reynolds, Simon Anderson, Shuvra Ray, Joel Mawdsley, Jeremy Sanderson, Mark A Samaan, Peter M Irving
The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre. GastroHep 2 (6) (2020)
Kelli DeLay, Manaswita Tappata, Kevin Z Huang, Nathaniel T Koutlas, Benjamin S Robey, Claire Fan, Swathi Eluri, Paul Menard-Katcher, Evan S Dellon
Long-term Continued Proton Pump Inhibitor Use is Common in Patients Diagnosed with Eosinophilic Esophagitis Despite Failure of Histologic Response: Data from a two-centre study: Long-term PPI Use in Patients with EoE. GastroHep 2 (6) (2020)

volume 2, number 1, 2019

Shria Kumar, Ravindra Sangitha, Irving Nachamkin, David C Metz
Resistance patterns of refractory H. pylori infection in a referral center in the Delaware Valley. GastroHep 2 (1) (2019)

volume 1, number 4, 2019

Niharika R Samala, Samer Gawrieh, Qing Tang, Spencer G Lourens, Vijay H Shah, Arun J Sanyal, Suthat Liangpunsakul, Naga Chalasani
Clinical Characteristics and Outcomes of Mild to Moderate Alcoholic Hepatitis. GastroHep 1 (4) (2019)

volume 1, number 6, 2019

Jack A Syage, Peter H R Green, Chaitan Khosla, Daniel C Adelman, Jennifer A Sealey-Voyksner, Joseph A Murray
Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet. GastroHep 1 (6) (2019)